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Abstract
Methylmercury (MeHg) exposure at high concentrations poses significant neurotoxic threat to humans
worldwide. The present study investigated the mechanisms of glutathione-mediated attenuation of MeHg
neurotoxicity in primary cortical culture. MeHg (5 μM) caused depletion of mono- and disulfide glutathione in

neuronal, glial and mixed cultures. Supplementation with exogenous glutathione, specifically glutathione
monoethyl ester (GSHME) protected against the MeHg induced neuronal death. MeHg caused increased reactive
oxygen species (ROS) formation measured by dichlorodihydrofluorescein (DCF) fluorescence with an early
increase at 30 min and a late increase at 6 h. This oxidative stress was prevented by the presence of either
GSHME or the free radical scavenger, trolox. While trolox was capable of quenching the ROS, it showed no
neuroprotection. Exposure to MeHg at subtoxic concentrations (3 μM) caused an increase in system
xc− mediated 14C-cystine uptake that was blocked by the protein synthesis inhibitor, cycloheximide (CHX).
Interestingly, blockade of the early ROS burst prevented the functional upregulation of system xc−. Inhibition of
multidrug resistance protein-1 (MRP1) potentiated MeHg neurotoxicity and increased cellular MeHg. Taken
together, these data suggest glutathione offers neuroprotection against MeHg toxicity in a manner dependent
on MRP1-mediated efflux.

Abbreviations
CPG carboxyphenylglycine
CGN cerebellar granular neurons
CHX cycloheximide
DCF dichlorodihydrofluorescein
GSHME glutathione monoethyl ester
ICP-MS inductively-coupled plasma mass spectrometry
LDH lactate dehydrogenase
MeHg methylmercury
MRP1 multi-drug resistance protein 1
NAC N-acetyl cysteine
ROS reactive oxygen species
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1. Introduction
Methylmercury (MeHg) is an ubiquitous neurotoxicant posing significant threat to humans when
ingested at high concentrations. Exposure to MeHg has been implicated as a factor in the development
of neurodegenerative diseases such as Alzheimer's Disease, Parkinson's Disease, and amyotrophic lateral
sclerosis (ALS) (Hock et al., 1998, Monnet-Tschudi et al., 2006, Praline et al., 2007). Humans are primarily
exposed to MeHg through consumption of contaminated fish and shellfish. MeHg is formed by
bacterial methylation of inorganic mercury in aquatic sediments (Clarkson, 1997). MeHg then travels up the food
chain and accumulates in fish and shellfish, and is subsequently consumed by humans (Mahaffey et al., 2004).
There is clear evidence for neurological deficits following exposure to high levels of mercury. For example, a
large release of mercury into Minamata Bay in Japan led to toxic levels of exposure and severe injury to the local
population, including neurological dysfunctions (Harada, 1995, Tsuda et al., 2009). In a separate incident,
methylmercury-contaminated seed grain was sent to a population in Iraq with its consumption leading to severe
neurological injuries (Myers et al., 2000). Acute exposure to high levels of mercury is known to target cerebellar
granular neurons(Fonnum and Lock, 2000), however, due to the location of damage in neurodegenerative
diseases, there is also interest in the effects of mercury on cortical neurons. While humans are exposed to other
forms of mercury, such as elemental mercury found in dental amalgam restorations, or ethylmercury found in
the commercial preservative, thimerosal, MeHg is of specific concern because it is easily absorbed in the
gastrointestinal tract, and readily traverses the blood–brain barrier (BBB) (Bridges and Zalups, 2005, Bridges and
Zalups, 2010).
Proposed mechanisms for MeHg neurotoxicity are primarily focused on four possibilities: disruption of
intracellular calcium and zinc ion homeostasis, likely involving mitochondrial deficits (Atchison and Hare,

1994, Kawanai et al., 2009), redox imbalance by increased production of reactive oxygen species and/or by
decreasing endogenous cellular antioxidant defenses (Ali et al., 1992, Yee and Choi, 1996, Aschner, 2000, Franco
et al., 2007, Amonpatumrat et al., 2008, Wang et al., 2009), direct interactions with free protein sulfhydryl
groups (Rooney, 2007), and inhibition of selenoenzymes, especially those involved in redox signaling (Carvalho
et al., 2008). The present study is aimed at determining the effects of MeHg on the glutathione (GSH) cycling
system and oxidative stress.
Astrocytes are thought to be responsible for de novo synthesis
of glutathione from glutamate, glycineand the rate limiting substrate, cysteine, which is brought into the
astrocytes primarily in its oxidized form, cystine (Kranich et al., 1998). Glutathione can be utilized by the cell to
reduce reactive oxygen species, for example, superoxide produced as a byproduct of mitochondrial energy
production rapidly reacts to form hydrogen peroxide which is then reduced by glutathione to form glutathionedisulfide(GSSG) and water in a reaction catalyzed by glutathione peroxidase. Glutathione may also be utilized as
a xenobiotic detoxicant as has been well characterized involving chemotherapeutics in cancertreatment (Salinas
and Wong, 1999). That is, glutathione can be directly conjugated to exogenous substrates via a disulfide
bond with the free sulfhydryl groups; these reactions are directed by a class of enzymes known as glutathione-Stransferases (GSTs) (Dringen, 2000, Dringen and Hirrlinger, 2003). GSH, GSSG and the glutathione-conjugates are
then exported from the cell in a glutathione-dependent manner via multi-drug resistance proteins (MRP),
specifically MRP1 in the CNS (Hirrlinger and Dringen, 2005, Minich et al., 2006). These glutathione molecules can
then be broken down in the extracellular space by glutathione reductase, amino-peptidase N, or gammaglutamyl transpeptidase. This metabolism produces the substrate cysteine, which can be taken up and utilized
by neurons to produce their own glutathione. In this way, neurons are dependent on astrocytes to supply
glutathione (Dringen et al., 1999). Since glutathione serves a dual role as both an antioxidant and detoxicant,
and both of these roles may offer independent protective mechanisms against MeHg, the present study
examines the impact of MeHg on these aspects of glutathione action.

2. Materials and methods
2.1. Materials
Timed pregnant Swiss Webster mice were obtained from Charles River Laboratories (Wilmington, DE,
USA). Serum was from Atlanta Biologicals (Atlanta, GA, USA). NADPH was from Applichem (Darmstadt,
Germany). Radiolabeled 14C-cystine was purchased from PerkinElmer (Boston, MA, USA). S-(4)carboxyphenylglycine (CPG) and MK571 were obtained from Tocris Bioscience (Ellisville, MO, USA). DCF was
from Molecular Probes (Eugene, OR, USA). All other chemicals were from Sigma (St. Louis, MO, USA).

2.2. Cortical cell cultures
Mixed cortical cell cultures containing glial and neuronal cells were prepared from fetal (15–16 day
gestation) mice as previously described (Lobner, 2000). Dissociated cortical cells were plated on 24-well plates
(2.0 cm2 surface area per well) coated with poly-d-lysine and laminin in Eagles’ Minimal Essential Medium
(MEM, Earle's salts, supplied glutamine-free) supplemented with 5% (v/v) heat-inactivated horse serum, 5%
(v/v) fetal bovine serum, 2 mM glutamine and d-glucose (total 21 mM). Neuronal cultures were prepared exactly
as above with the addition of 10 μM cytosine aribinocide 48 h after plating to inhibit glial replication (Dugan et
al., 1995, Rush et al., 2010). Cultures were plated at approximately 8 hemispheres per plate in a volume of
500 μl per well. Glial cultures were prepared as described for mixed cultures from cortical tissue taken from
post-natal day 1–3 mice and plated at approximately 3 hemispheres per plate (Choi et al., 1987, Schwartz and
Wilson, 1992, Rush et al., 2009). Cultures were maintained in humidified 5% CO2 incubators at 37 °C. Mice were
handled in accordance with a protocol approved by our institutional animal care committee and in compliance
with the Public Health Service Policy on Humane Care and Use of Laboratory Animals. All experiments were
performed in media identical to growth media except lacking serum (MS) at a volume of 400 μl per well. All
experiments were performed on mixed cortical cultures, except where noted.

2.3. Assay of neuronal death
Cell death was assessed in cultures by the measurement of lactate dehydrogenase (LDH), released from
damaged or destroyed cells, in the extracellular fluid 24 h after the beginning of the insult. Insults were
performed by washing cultures into MS or MS containing the indicated chemicals and incubating overnight.
Control LDH levels were subtracted from insult LDH values, and results normalized to 100% neuronal
death caused by 500 μM NMDA. Control experiments have shown previously that the efflux of LDH occurring
from either necrotic or apoptotic cells is proportional to the number of cells damaged or destroyed (Koh and
Choi, 1987, Lobner, 2000). Trypan blue staining indicated that the cell death observed was neuron selective.
Cell-free experiments were performed to exclude the possibility of direct inhibition of LDH by MeHg. That is,
MeHg at concentrations up to 10 μM do not alter the quantification of an LDH standard.

2.4. Glutathione assay
Total cellular glutathione and media glutathione were assayed using a modified enzymatic
method(Baker et al., 1990, Lobner et al., 2003). Cultures were washed into MS with or without MeHg (5 μM) and
incubated for 6 h. Media samples of 25 μl were taken after the drug application period and assayed as aliquots
of supernatant below. Cultures were washed with cold (4 °C) HEPES buffered salinesolution, dissolved in 200 μl
of 1% sulfosalicylic acid, and centrifuged. A 25 μl aliquot of the supernatant was combined with 150 μl of 0.1 M
phosphate/5 mM EDTA buffer, 10 μl of 20 mM dithiobis-2-nitrobenzoic acid, 100 μl of 5 mM nicotinamide
adenine dinucleotide phosphate (NADPH), and 0.2 U of glutathione reductase. Total glutathione was determined
by kinetic analysis of absorbancechanges at 402 nm for 1.5 min, with concentrations determined by comparison
to a standard curve. GSSG was measured as above except samples were treated with 2-vinylpyridine
and triethanolaminefor 1 h prior to beginning the reaction. Cell-free experiments were performed to exclude
the possibility of assay inhibition by the experimental reagents used. Due to inter-plate culture variance in
absolute glutathione measures data in Table 1 are reported as percent respective intra-plate control glutathione
measures. Untreated control values across all culture types were typically in the following ranges (represented
as mean nmol/well): 1.99–3.33 cellular GSH, 0.24–0.50 media GSH, 0.14–0.74 cellular GSSG, 0.060–0.16 media
GSSG.
Table 1. Effect of MeHg (5 μM) on glutathione levels in glial, neuronal and mixed cortical cultures after 6 h
exposure.
Culture type GSH
GSSG
Cellular
Media
Cellular
Media
Mixed
83.4 ± 4.7 22.8 ± 1.0 60.7 ± 5.7 12.6 ± 2.4
Glia
44.8 ± 5.2 62.3 ± 9.8 18.4 ± 2.9 29.3 ± 3.7
Neurons
59.6 ± 6.5 36.9 ± 1.8 20.6 ± 6.2 N/D
Results are expressed as % untreated control (mean ± SEM, n = 8–16). All values are significantly different from
control. N/D = not detectable.

2.5. Assay for oxidative stress
Oxidative stress was measured with 5-(and -6)-2′7′-dichlorodihydrofluorescein diacetate (DCF-DA) using
a fluorescent plate reader following a modification of a previous method (Wang and Joseph, 1999, Lobner et al.,
2007). 10 μM of the non-fluorescent, lipophilic compound DCF-DA is added to the cultures for 30 min where it is
de-esterified and may be oxidized to fluorescent DCF (2′,7′-dichlorofluorescein). Fluorescence is read using a
Fluoroskan Ascent plate reader (Thermo LabSystems) with excitation and emission filters set to 485 nm and
538 nm, respectively. Background fluorescence (no DCF added) was subtracted and the results normalized to
control conditions.

2.6. 14C-cystine uptake
Radiolabeled cystine uptake was performed as previously described with modifications (Liu et al., 2009).
Cultures were exposed to MS containing the indicated drug treatments for 24 h, or for 1 h followed by 23 h in

drug-free MS. 24 h after the start of the experiment, cultures were washed into HEPES buffered saline solution
and immediately exposed to 14C-cystine (0.025 μCi/mL, 200 nM total cystine) for 20 min. Following 14C-cystine
exposure, cultures were washed with ice cold HEPES buffered saline solution and dissolved in 250 μl
warm sodium dodecyl sulfate (0.1%). An aliquot (200 μl) was removed and added to scintillation fluid for
counting. Values were normalized to 14C-cystine uptake in untreated controls of the same experimental plate.

2.7. Determination of MeHg content in cells by ICP-MS
Following 6 h exposure to MS with or without the indicated treatments, cultures were washed 3× with
cold MS and then dissolved in 100 μl 1% sulfosalicylic acid. Samples were combined with 900 μl 5% HNO3
containing 500 ppb Au and digested at 70 °C for 2 h. Digestions were then centrifuged at 6000 × g for 5 min and
the supernatants were diluted with an additional 1 mL of 5% HNO3. Mercurycontent was determined using a
Micromass Platform ICP-MS controlled by MassLynx software (Waters Corporation, Milford,
MA). Isotopes 198Hg, 199Hg, 200Hg, 201Hg, 202Hg, and 204Hg were recorded and total mercury was quantified by
comparing sample responses to those produced by commercial standards treated identically to the samples.

2.8. Statistical analysis
Differences between test groups were examined for statistical significance by means of one-way ANOVA
followed by the Student–Neuman Keuls post hoc analysis, with p < 0.05 being considered significant.

3. Results
Methylmercury (0.3–10 μM) exposure induced concentration-dependent neurotoxicity in mixed
neuronal and glial cortical cultures 24 h after onset of insult (Fig. 1). Cell death was assayed by release of the
cytosolic enzyme LDH 24 h after the beginning of the insult. Further, trypan blue staining of these cultures
demonstrated that the MeHg-induced toxicity at the concentrations tested was purely neuronal (data not
shown). From these data we chose 5 μM MeHg as a moderate insult for subsequent experiments as it allows
bidirectional alterations to MeHg-induced neurotoxicity (i.e. neuroprotectionor potentiation). For other
experiments we used 3 μM MeHg as a low-level insult as no significant neurotoxicity was observed at this
concentration (Fig. 1).

Fig. 1. Concentration response curve of MeHg (24 h exposure) on LDH release in primary cortical culture. Results
are expressed as mean + SEM (n = 8–16). *Significant difference from untreated control.
MeHg toxicity has been shown to cause glutathione depletion in several cell types (Kitahara et al.,
1993, Kaur et al., 2006, Amonpatumrat et al., 2008). We found that exposure of mixed neural and glial, pure
neuronal and pure glial cultures to 5 μM MeHg significantly decreased total GSH and disulfide
glutathione (GSSG) levels in the cells as well as in the extracellular media (Table 1). This glutathionedepletion
occurred following a 6 h MeHg exposure, a time that precedes cell death as no LDH activity was detectable at
this time (data not shown). We next tested whether glutathione supplementation or the addition of the free
radical scavenger, trolox could protect the neurons. 24 h co-treatment of MeHg with glutathione

monoethyl ester (GSHME) but not trolox, was neuroprotective (Fig. 2). Since glutathione supplementation was
protective, and this effect could be due to its nature as an antioxidant or a xenobiotic detoxicant, we next
assessed the abilities of GSHME and Trolox to block MeHg-induced oxidative stress.

Fig. 2. MeHg-induced neuronal death is attenuated by glutathione monoethyl ester (GSHME, 100 μM) but
not trolox (100 μM). Results are expressed as mean + SEM (n = 16–20). *Significantly different from MeHgalone.
Mixed neuronal and glial cortical cultures exhibited a biphasic pattern of oxidative stress induced by
exposure to 5 μM MeHg for 0, 30, 60, 180 or 360 min (Fig. 3) as measured by fluorescence of DCF.
DCF fluorescence peaked at 30 min, returned to control levels at 3 h and increased once again by 6 h following
onset of MeHg insult. Both 100 μM GSHME and 100 μM trolox were capable of preventing the MeHg-induced
rise in DCF fluorescence indicative of their ability to block MeHg-induced oxidative stress. However, trolox was
much more effective than GSHME actually decreasing the DCF signal well below control levels.

Fig. 3. Timecourse of MeHg (5 μM) induced ROS formation as detected by DCF fluorescence. Results are
expressed as mean + SEM (n = 8–16) after normalizing to average fluorescence of untreated controls (i.e. DCF
only). *Significantly different from untreated controls.
To further examine MeHg induced alterations to glutathione-related systems, we next tested whether
low-level MeHg exposure had an effect on cellular uptake of cystine, the rate limiting substrate for GSH
synthesis. Acute exposure to MeHg had no effect on 14C-cystine uptake (3 μM MeHg, 20 min exposure, data not
shown); however, 24-h exposure to low-level MeHg (3 μM) caused a robust increase in subsequent 14C-cystine
uptake that was blocked by co-treatment with the protein synthesisinhibitor, cycloheximide (CHX, 500 ng/mL)
(Fig. 4A). To determine whether the MeHg-induced increase in cystine uptake was mediated by
cystine/glutamate exchange, we tested the effects of an inhibitor of this system, CPG (300 μM, present only

during the 20 min uptake period). The finding that CPG blocked the MeHg-induced increase in cystine uptake
indicates that the increase was entirely mediated by functional upregulation of system xc−. When attempting to
determine the effect of trolox on the MeHg-induced increase, we found that overnight exposure to trolox alone
induced a large increase in subsequent cystine uptake (data not shown). To avoid this complication we used an
altered protocol shortening the exposure time to the trolox and/or MeHg to 1 h, followed by a 23 h incubationin
identical exposure media except lacking the trolox and MeHg. 60 min exposure to MeHg (3 μM) produced a
similar increase in xCT-mediated cystine uptake 23 h later (Fig. 4B). Co-treatment with trolox during this period
blocked this increase while trolox alone for 60 min had no effect on uptake.

Fig. 4. Subtoxic MeHg exposure causes a robust increase in system xc− mediated 14C-cystine uptake. (A) Cultures
were exposed to MeHg (3 μM), cycloheximide (CHX, 500 ng/mL), or in combination for 24 h prior to measuring
uptake. Carboxyphenylglycine (CPG, 300 μM) was present only during the 20 min uptake period. (B) Cultures
were exposed to MeHg (3 μM), trolox (100 μM) or in combination for 60 min, washed into drug-free media and
incubated overnight (23 h) prior to assay for cystine uptake. Results are expressed as mean + SEM (n = 8–16)
after normalizing to untreated control uptake. *Significantly different from control.
It is possible that glutathione conjugates to MeHg intracellularly and that this conjugate is exported
via MRP1. To test whether the export of glutathione is necessary for its protective capabilities, we co-treated
cultures with MeHg and an inhibitor of MRP1, MK571. MK571 alone caused no significant cell toxicity; however,
by inhibiting MRP1-mediated glutathione export MeHg neurotoxicity was severely potentiated (Fig. 5A).
Supporting the idea that MeHg conjugates to GSH, we found that inhibiting MRP1-mediated glutathione export
with MK571 led to a doubling of MeHg accumulation within the cellular compartment (Fig. 5B).
Supplementation with GSHME during the MeHg treatment had no effect on mercury accumulation in the cells
(data not shown).

Fig. 5. Blockade of glutathione efflux augments MeHg toxicity and cellular accumulation of mercury. (A) Cultures
were exposed to MeHg (5 μM), MK571 (10 μM), or both in combination with or without GSHME (100 μM) for
24 h at which time samples were taken and neuronal death quantified by LDH release. Results are expressed as
mean + SEM (n = 8–12). *Significantly different from untreated control, #significantly different from MeHg-only
treated. (B) Cultures were exposed to MeHg (5 μM) in the presence of GSHME (100 μM) or MK571 (50 μM) for
6 h. Samples were then taken and subsequently analyzed for mercury content by ICP-MS. Results are expressed
as mean + SEM (n = 3–6).

4. Discussion
The present study offers several insights into the contributions of alterations in glutathione cycling
and oxidative stress to methylmercury-induced neurotoxicity. We observed significant toxicity with overnight
exposure of mixed cortical cultures to 5 μM MeHg. This concentration is similar to those used in other studies
demonstrating cytotoxicity, oxidative stress and mitochondrial deficits in cortical and cerebellar
granular neuron (CGN) cultures (Gasso et al., 2001, Morken et al., 2005, Kaur et al., 2006, Yin et al., 2007).
However, it is important to note that CGNs have been shown to be more sensitive to MeHg toxicity (Sarafian
and Verity, 1991, Marty and Atchison, 1997, Sakaue et al., 2005). Though not the only factor recognized, the
increased sensitivity of CGNs has been posited as attributable to the relatively low glutathione content of these
cells (Yee and Choi, 1996, Shafer et al., 2002, Kaur et al., 2007, Wang et al., 2009).
Previous studies have shown that MeHg causes a depletion of cellular glutathione (Yee and Choi,
1996, Franco et al., 2007, Amonpatumrat et al., 2008, Wang et al., 2009). Here, we also report that MeHg
depletes both total and disulfide glutathione in cortical culture; total GSH and disulfide GSSG were decreased in
cellular and media samples from glia-enriched, neuron-enriched and mixed cultures. GSH can reduce free
radicals or eliminate exogenous molecules from the cell. The MeHg-induced loss of glutathione may be due to
the formation of ROS and subsequent use of GSH by the cells to reduce the oxidative damage. However, since

reduction of oxidative stress by GSH results in the formation of GSSG, the observed depletion of both GSH and
GSSG suggests that the loss of glutathione was not due to oxidative stress. This data is consistent with
the hypothesis that glutathione is acting to detoxify MeHg by direct conjugation which may render the utilized
GSH molecules undetectable by our assay, and perhaps unrecoverable by the cell.
It has been shown that modulation of cellular thiols (including GSH) alters sensitivity to MeHg in culture
(Kaur et al., 2006) and that exogenous supply of glutathione precursors such as N-acetyl-cysteine (NAC)
or cystine is neuroprotective (Fujiyama et al., 1994, Kaur et al., 2006, Kaur et al., 2007). Specifically, NAC is able
to boost cellular GSH availability and leads to decreased MeHg-induced cytotoxicity and ROS formation.
Inhibition of glutathione synthesis with buthionine sulfoxamine (BSO) increases sensitivity to MeHg and
increases subsequent ROS formation (Toyama et al., 2011). These studies also demonstrate that modulation of
glutathione availability alters cellular ROS formation in response to MeHg insult. Further, this ROS formation is
sensitive to antioxidants (Gasso et al., 2001, Shanker and Aschner, 2003, Kaur et al., 2010). Importantly,
however, in our hands troloxdoes not offer the neuroprotective capacity that glutathione supplementation with
GSHME provides. This suggests that oxidative stress alone is not primary to the toxicity of MeHg under these
conditions. Others have shown that trolox does offer neuroprotection against early MeHg-induced
mitochondrial deficits detected by MTT metabolism after short, 1 h exposure (Kaur et al., 2010). Notably,
however, these studies did not investigate later timepoints as seen in the present data.
An important action of MeHg is the inhibition of selenoproteins. Among the selenoproteins that MeHg
has been shown to inhibit are thioredoxin reductase and thioredoxin-glutathione peroxidase(Carvalho et al.,
2008, Reeves and Hoffmann, 2009, Branco et al., 2011). In fact, the IC50 for the inhibition of thioredoxin
reductase 1 is 9 nM (Carvalho et al., 2008); therefore, at the concentrations of MeHg used in the current study
this enzyme, and similar selenoproteins, are likely greatly inhibited. Therefore, it is clear that interaction with
selenoproteins could be a mechanism of MeHg induced GSH depletion and oxidative stress. However, while
preincubation with selenomethionine has been shown to attenuate MeHg induced production of reactive
oxygen species, it did not prevent depletion of GSH (Kaur et al., 2009). Although, dietary selenium is known to
be protective against MeHg exposure (Ralston and Raymond, 2010).
MeHg can also inhibit other enzymes important for the cells response to oxidative stress, such as
thioredoxin and glutathione reductase (Carvalho et al., 2008). However, the inhibition of glutathione
reductase was found to only occur in vitro and not in cells treated with MeHg (Carvalho et al., 2008).
We also examined the function of the cystine–glutamate antiporter in response to MeHg exposure by
radiolabeled 14C-cystine uptake. As discussed above, cystine uptake is an important aspect of glutathione
synthesis and subsequent cycling. Low-level MeHg insult induced a robust increase in cystine uptake.
This functional upregulation of xCT was blocked by CHX suggesting that the upregulation requires translation of
new protein. As well, CPG blocked this increased radioliganduptake to CPG-treated control levels suggesting the
entire MeHg-induced increase was mediated by system xc−. Trolox also blocked the MeHg-increased cystine
uptake. Considering that upregulation of xCT is likely an endogenous mechanism of cytoprotection in response
to MeHg-insult, the fact that trolox blocks upregulation of xCT may account for the inability of trolox to protect
against the neuronal injury. The most likely mechanism for increased system xc− activity is upregulation of xCT
by activation of the nrf2-ARE pathway (Mysona et al., 2009, Wang et al., 2009, Qin et al., 2010). Consistent with
this explanation is a recent report demonstrating nrf2-dependent methylmercury detoxificationin hepatocytes
(Toyama et al., 2011) and an earlier report in astrocytes (Wang et al., 2009).
The current data indicate that blockade of oxidative stress alone is insufficient to prevent MeHginduced neuronal death, and that elimination of MeHg from the cell by conjugation to GSH is necessary.
Consistent with this, inhibition of glutathione export via the MRP1 inhibitor, MK571, not only potentiated MeHginduced neurotoxicity, but this potentiation was associated with increased accumulation of MeHg in the cell.
Similar results have been reported in primary mouse hepatocytes where it was found that upregulation
of MRP1 by isothiocyanates decreased MeHg accumulation and toxicity (Toyama et al., 2011). Interestingly, and
consistent with a previous report using NAC (Kaur et al., 2006), glutathione supplementation with GSHME did
not affect MeHg accumulation in the cell. Trolox has previously been reported to have no effect on MeHg
accumulation nor on glutathione availability (Kaur et al., 2010); these and the present data, support the

assertion that oxidative stress is not primary to MeHg-induced neurotoxicity. Rather, conjugation with MeHg
and subsequent export of glutathione from the cytosol is crucial to alleviate or prevent MeHg-induced
neurotoxicity and that solely blocking oxidative stress is not likely to offer significant neuroprotection.
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